A Study of SL-325 in Crohn's Disease Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The primary purpose of this study is to evaluate the efficacy of SL-325 in adult participants with moderate to severely active Crohn\'s disease. The study consists of a screening period of up to 6 weeks, a 12-week induction period, 38-week maintenance period, 52-week long-term extension period, and a 10-week follow-up period.
Epistemonikos ID: 5f205d7108e0bb5705111d7cf82b506270de2f22
First added on: Aug 11, 2026